Patient-reported outcomes and diabetes technology: a systematic review of the literature.

Richard R. Rubin, Mark Peyrot

    Research output: Contribution to journalReview article

    Abstract

    Advanced diabetes technology should have benefits not only in terms of clinical outcomes, but also in terms of patient-reported outcomes. The objective of this paper is to review the methodology and findings of studies that assessed the effects of diabetes technologies such as continuous subcutaneous insulin infusion (CSII), continuous glucose monitoring (CGM), and integrated CSII/CGM on patientreported outcomes. The existing literature in pediatric and adult patients is limited, so there is no conclusive evidence that use of CSII, CGM, or integrated CSII/CGM systems produce improved patient-reported outcomes, but most studies provide evidence that these technologies yield some patient-reported outcomes advantages, and few indicate any disadvantages. We expect that more robust studies in the future will provide further evidence regarding the impact of these technologies for patient-reported outcomes, including general health-related quality-of-life, diabetesspecific quality-of-life, treatment satisfaction, and treatment preference.

    Original languageEnglish (US)
    Pages (from-to)405-412
    Number of pages8
    JournalPediatric endocrinology reviews : PER
    Volume7 Suppl 3
    StatePublished - Aug 2010

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health
    • Endocrinology, Diabetes and Metabolism

    Fingerprint Dive into the research topics of 'Patient-reported outcomes and diabetes technology: a systematic review of the literature.'. Together they form a unique fingerprint.

  • Cite this